In the News

May 11

May 11, 2020 TOBI Blog, Education, News COVID, orthopedics

ON Foundation Grants – Articles on How Corona Affects Orthopedics

How does corona affect orthopedics? ON Foundation is awarding two 1'500 CHF Literature Grants for articles on the matter. Many of us are affected by the Corona Pandemic and work from home, not being able to practice and/or research as usual. ON Foundation therefore is offering three (3) open Literature Grants over 2'000 CHF mainly to cover open access publication fees. Your application does need to have a strong orthoregeneration aspect. Three (3) grants will be awarded. Application Deadline: May...

Mesoblast Stem Cell Therapy Study shows 83% Survival in patients on Ventilators from COVID-19

News was announced today from Biospace that patients with ARDS (Acute Respiratory Distress) demonstrated an 83% survival after 2 IV infusions of Mesoblast’s product Ryoncil (remestemcel-L). This med is NOT FDA approved for treating COVID-19 according to BioSpace. In the study, 9/12 patients came off ventilators within 10 days, with 7 patients discharged from the hospital. According the report patients were treated in New York City’s Mt Sinai hospital under an emergency investigational new drug (IND) application or via expanded access portal....

New COVID-19 Research Investigating Plasma and Stem Cell Therapies, Anti-malarial, Antiviral and Antibiotic Meds while Vaccines are Developed

With up to 1 year before a successful vaccine may be developed, scientists are looking at existing medications as well as cellular therapies to combat COVID and the inflammation/cytokine (protein) storm that attacks the lungs and vital organs. With Millions of people affected around the world, leading researchers are looking at everything from anti-malarial medication (Hydroxychloroquine) and antibiotics (Azithromycin or Z pack) to cell based therapies. Some cell based therapies include using “convalescent plasma” transfusion. I.e getting plasma from...